Home Supplements How We Rate Blog
Myricetin (3,5,7,3',4',5'-hexahydroxyflavone)

Myricetin

Research reviewed: 2023-2025

Myricetin (Myricetin (3,5,7,3',4',5'-hexahydroxyflavone)) is a dietary supplement with 12 published peer-reviewed studies involving 387 participants, researched for Cancer Prevention, Diabetes & Metabolic Health, Neuroprotection & Antioxidant and 3 more areas.

12
Studies
387
Participants
2007–2025
Research Span

Evidence at a Glance

Strength is scored by study design, sample size, study type, and outcomes

Overall: Moderate Evidence

Cancer Prevention

Moderate
3 studies 0 of 3 positive 30,524 participants 2 human

Diabetes & Metabolic Health

Moderate
2 studies 1 of 2 positive 62 participants 1 human

Neuroprotection & Antioxidant

Weak
2 studies 1 of 2 positive 0 participants 0 human

Reviews & Mechanisms

Weak
2 studies 0 of 2 positive 0 participants 0 human

Blood Sugar

Moderate
1 study 1 of 1 positive 15 participants

Mood & Mental Health

Moderate
2 studies 1 of 2 positive 372 participants

Research Visualised

Visual breakdown of the clinical data.

Study Quality Breakdown

What types of studies were conducted

0/12
Randomised
0/12
Double-Blind
0/12
Placebo-Controlled

Participants Per Study

Larger samples = more reliable results

Study 1 (2007)
29,133
Study 2 (2012)
1
Study 3 (2010)
1,390
Study 4 (2021)
56
Study 5 (2010)
6
Study 6 (2011)
0
Study 7 (2014)
0
Study 8 (2013)
0

Research Timeline

When the studies were published

1
2007
2
2010
1
2011
1
2012
1
2013
1
2014
1
2021
1
2022
1
2023
1
2024
1
2025

All Studies

Detailed breakdown of each trial. Click to expand.

Cancer Prevention

1

To investigate dietary myricetin intake and prostate cancer risk.

2007 29,133 participants 14 years follow-up Dietary myricetin intake (observational)
Human Study Mixed

Study Type

Prospective cohort

Purpose

To investigate dietary myricetin intake and prostate cancer risk.

Dose

Dietary myricetin intake (observational)

Participants

29,133 men in Health Professionals Follow-up Study

Duration

14 years follow-up

Results

Higher dietary myricetin intake associated with 22% lower prostate cancer risk; strongest protection for aggressive disease.

How They Measured It

FFQ dietary assessment; prostate cancer incidence from registry

Read full study
2

To characterise myricetin's pro-apoptotic and anti-migratory effects in pancreatic cancer cells.

2012 1 participants 24-72 hours 10-100 µM myricetin
Review/Other Positive

Study Type

In vitro mechanistic study

Purpose

To characterise myricetin's pro-apoptotic and anti-migratory effects in pancreatic cancer cells.

Dose

10-100 µM myricetin

Participants

PANC-1 and MIAPaCa-2 pancreatic cancer cells

Duration

24-72 hours

Results

Myricetin induced dose-dependent apoptosis via both extrinsic and intrinsic pathways; significantly inhibited cancer cell invasion and MMP-9 expression.

How They Measured It

Caspase cascade, PARP cleavage, Matrigel invasion assay, MMP-9 expression

Read full study
3

To evaluate dietary myricetin intake and lung cancer risk.

2010 1390 participants Case-control Dietary intake (observational)
Human Study Mixed

Study Type

Case-control study

Purpose

To evaluate dietary myricetin intake and lung cancer risk.

Dose

Dietary intake (observational)

Participants

1390 lung cancer cases and controls

Duration

Case-control

Results

Highest tertile of myricetin intake associated with 28% lower lung cancer risk; significance strongest in never-smokers.

How They Measured It

FFQ; lung cancer case-control

Read full study

Diabetes & Metabolic Health

4

To evaluate myricetin supplementation on insulin resistance and glycaemic control.

2021 56 participants 8 weeks 50 mg myricetin daily
Human Study Positive

Study Type

RCT

Purpose

To evaluate myricetin supplementation on insulin resistance and glycaemic control.

Dose

50 mg myricetin daily

Participants

56 adults with type 2 diabetes

Duration

8 weeks

Results

Significant reductions in fasting glucose (-11%), HOMA-IR (-18%), and HbA1c (-0.5%) compared to placebo.

How They Measured It

Fasting glucose, HOMA-IR, HbA1c, fasting insulin

Read full study
5

To investigate myricetin's mechanisms for improving insulin sensitivity and glucose uptake.

2010 6 participants 48 hours / 4 weeks 5-25 µM myricetin in vitro; 50-200 mg/kg in rats
Review/Other Mixed

Study Type

In vitro and animal study

Purpose

To investigate myricetin's mechanisms for improving insulin sensitivity and glucose uptake.

Dose

5-25 µM myricetin in vitro; 50-200 mg/kg in rats

Participants

L6 muscle cells; streptozotocin-diabetic rats

Duration

48 hours / 4 weeks

Results

Myricetin promoted GLUT4 translocation via PI3K/Akt pathway and enhanced muscle glucose uptake; insulin sensitising effects confirmed in diabetic rat model.

How They Measured It

GLUT4 translocation, PI3K/Akt pathway activation, glucose uptake in muscle cells

Read full study

Neuroprotection & Antioxidant

6

To assess myricetin's neuroprotective effects against beta-amyloid-induced toxicity.

2011 ? participants 48-hour Abeta exposure 1-20 µM myricetin
Review/Other Positive

Study Type

In vitro study

Purpose

To assess myricetin's neuroprotective effects against beta-amyloid-induced toxicity.

Dose

1-20 µM myricetin

Participants

Primary rat hippocampal neurons

Duration

48-hour Abeta exposure

Results

Myricetin significantly protected neurons from Abeta toxicity; reduced tau hyperphosphorylation via GSK-3beta inhibition; decreased neuronal ROS by 60%.

How They Measured It

Neuronal viability, ROS measurement, tau phosphorylation, GSK-3beta activity

Read full study
7

To evaluate myricetin on cognitive function and oxidative stress in aged mice.

2014 ? participants 4 weeks 10-30 mg/kg myricetin orally
Review/Other Positive

Study Type

Animal study

Purpose

To evaluate myricetin on cognitive function and oxidative stress in aged mice.

Dose

10-30 mg/kg myricetin orally

Participants

Aged D-galactose-induced aging mouse model

Duration

4 weeks

Results

Myricetin significantly improved spatial memory and passive avoidance; reduced brain oxidative stress markers; enhanced brain antioxidant enzyme activities.

How They Measured It

Morris water maze, passive avoidance test, brain MDA, SOD

Read full study

Reviews & Mechanisms

8

To pool evidence on flavonoid intake (including myricetin) and cancer risk reduction.

2013 ? participants Review Dietary flavonoid exposure
Review/Other Mixed

Study Type

Meta-analysis

Purpose

To pool evidence on flavonoid intake (including myricetin) and cancer risk reduction.

Dose

Dietary flavonoid exposure

Participants

Multiple studies pooled

Duration

Review

Results

Myricetin exhibited the strongest inverse association with prostate cancer in pooled analysis; also protective for lung and colorectal cancer.

How They Measured It

Pooled RR from prospective cohorts and case-controls

Read full study
9

To review myricetin's full spectrum of pharmacological activities.

2022 ? participants Review Varied
Review/Other Mixed

Study Type

Systematic review

Purpose

To review myricetin's full spectrum of pharmacological activities.

Dose

Varied

Participants

Multiple studies reviewed

Duration

Review

Results

Myricetin exhibits potent antioxidant, anti-diabetic, anti-cancer, and neuroprotective properties; bioavailability limitations require formulation strategies for clinical application.

How They Measured It

Comprehensive literature synthesis

Read full study

Blood Sugar

10

Imera cultivar carob: clinical glycemic effects and phytochemical profile.

2025 15 participants 1 months See study
Human Study Positive

Study Type

RCT

Purpose

Imera cultivar carob: clinical glycemic effects and phytochemical profile.

Dose

See study

Participants

15 participants

Duration

1 months

Results

significantly lowered glucose levels (109.

How They Measured It

PubMed PMID: 41166808. Food Chem

Read full study

Mood & Mental Health

11

Consumption of Sylimarin, Pyrroloquinoline Quinone Sodium Salt and Myricetin: Effects on Alcohol Levels and Markers of Oxidative Stress-A Pilot Study.

2024 ? participants 1 weeks See study
Human Study Mixed

Study Type

RCT

Purpose

Consumption of Sylimarin, Pyrroloquinoline Quinone Sodium Salt and Myricetin: Effects on Alcohol Levels and Markers of Oxidative Stress-A Pilot Study.

Dose

See study

Participants

Not specified

Duration

1 weeks

Results

CONCLUSION: After the administration of Si.

How They Measured It

PubMed PMID: 39275279. Nutrients

Read full study
12

[Efficacy, safety, and mechanism of Huangkui Capsules in treating chronic kidney disease: Meta-analysis and integrative bioinformatics].

2023 372 participants 24 weeks See study
Human Study Positive

Study Type

Meta-Analysis

Purpose

[Efficacy, safety, and mechanism of Huangkui Capsules in treating chronic kidney disease: Meta-analysis and integrative bioinformatics].

Dose

See study

Participants

372 participants

Duration

24 weeks

Results

significantly reduced urine protein, Scr, and BUN.

How They Measured It

PubMed PMID: 37802876. Zhongguo Zhong Yao Za Zhi

Read full study

Frequently Asked Questions

Common questions about Myricetin research

What does the research say about Myricetin?

There are currently 12 peer-reviewed studies on Myricetin (Myricetin (3,5,7,3',4',5'-hexahydroxyflavone)), involving 387 total participants. Research covers Cancer prevention, Diabetes management, Neuroprotection and 1 more areas. The overall evidence strength is rated as Moderate.

How strong is the evidence for Myricetin?

The evidence is currently rated as "Moderate Evidence". This rating is based on study design quality (randomisation, blinding, placebo controls), sample sizes, study types (6 human studies), and reported outcomes.

What health goals has Myricetin been studied for?

Myricetin has been researched for: Cancer prevention, Diabetes management, Neuroprotection, Antioxidant protection. Each area has its own body of evidence which you can explore in the study breakdowns above.

Are the studies on Myricetin based on human trials?

Yes, 6 out of 12 studies are human trials. Human trials carry more weight in our evidence scoring system.